{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:38:01Z","timestamp":1793317081043,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.metabol.2026.156716","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:17:14Z","timestamp":1785194234000},"page":"156716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023"],"prefix":"10.1016","volume":"183","author":[{"given":"Jayanth","family":"Jayabaskaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinithy","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haryo Raden","family":"Himan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest En-Rae","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwyneth","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S. Jocelyn","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamas A.","family":"Mamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Hausenloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0640-0430","authenticated-orcid":false,"given":"Nicholas W.S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10513","key":"10.1016\/j.metabol.2026.156716_bb0005","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the global burden of disease study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.metabol.2026.156716_bb0010","article-title":"The epidemiology and burden of injury in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the global burden of disease study 2021","volume":"10","year":"2025","journal-title":"Lancet Public Health"},{"issue":"4","key":"10.1016\/j.metabol.2026.156716_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41569-025-01220-4","article-title":"The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges","volume":"23","author":"Chew","year":"2026","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2026.156716_bb0020","unstructured":"GBD 2021 ASEAN Cardiovascular Diseases Collaborators. The epidemiology and burden of cardiovascular diseases in countries of the Association of Southeast Asian Nations (ASEAN), 1990\u20132021: findings from the Global Burden of Disease Study 2021. Lancet Public Health 2025;10(6):e467-e79."},{"issue":"21","key":"10.1016\/j.metabol.2026.156716_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.043629","article-title":"Global trends and forecast of cardiovascular diseases, Cancer, and shared risk factors: insights from the GBD 2021","volume":"14","author":"Koo","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2026.156716_bb0030","article-title":"Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort","volume":"37","author":"Chew","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.metabol.2026.156716_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101405","article-title":"Population estimates, trends, characteristics and prognostic outcomes of cardiovascular-kidney-liver-metabolic health: a population-based study","volume":"25","author":"Chen","year":"2026","journal-title":"Am J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.metabol.2026.156716_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3502","article-title":"Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors","volume":"38","author":"Silveira Rossi","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"10.1016\/j.metabol.2026.156716_bb0045","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.metabol.2026.156716_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00059-024-05235-4","article-title":"Increased cardiovascular risk in patients with chronic kidney disease","volume":"49","author":"Vondenhoff","year":"2024","journal-title":"Herz"},{"key":"10.1016\/j.metabol.2026.156716_bb0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.amjcard.2022.05.018","article-title":"Prognostically distinct phenotypes of metabolic health beyond obesity in aortic stenosis","volume":"178","author":"Chew","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2026.156716_bb0060","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-026-02925-3","article-title":"Long-term prognosis of coexistent metabolic dysfunction-associated steatotic liver disease and chronic kidney disease following acute myocardial infarction","author":"Zhang","year":"2026","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156716_bb0065","article-title":"Navigating the crossroads: understanding the link between chronic kidney disease and cardiovascular health","volume":"15","author":"Saeed","year":"2023","journal-title":"Cureus"},{"issue":"20","key":"10.1016\/j.metabol.2026.156716_bb0070","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.metabol.2026.156716_bb0075","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehaf314","article-title":"Clinical staging to guide management of metabolic disorders and their sequelae: a European atherosclerosis society consensus statement","volume":"46","author":"Romeo","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2026.156716_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111652","article-title":"Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population","volume":"211","author":"Chew","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.metabol.2026.156716_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11886-024-02025-6","article-title":"The global epidemic of metabolic fatty liver disease","volume":"26","author":"Lee","year":"2024","journal-title":"Curr Cardiol Rep"},{"issue":"19","key":"10.1016\/j.metabol.2026.156716_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.041834","article-title":"Population-based study on the coexistence of metabolic dysfunction-associated Steatotic liver disease and chronic kidney disease","volume":"14","author":"Goh","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2026.156716_bb0095","unstructured":"Ndumele CE, Rodriguez F, Dixon DL, Khan SS, Mukherjee D, Bajaj M, et al. 2026 AHA\/ACC\/ADA\/ASN guideline for the prevention, detection, evaluation, and management of cardiovascular-kidney-metabolic syndrome: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol 2026;87(22s):e1889-e2007."},{"issue":"11","key":"10.1016\/j.metabol.2026.156716_bb0100","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.125.325602","article-title":"Cardiovascular, kidney, liver, and metabolic interactions in heart failure: breaking down silos","volume":"136","author":"Lee","year":"2025","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.metabol.2026.156716_bb0105","article-title":"Cardiovascular-renal-hepatic-metabolic syndrome: interlinked pathophysiology and integrated management approach","volume":"17","author":"Arragan Lezama","year":"2025","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.metabol.2026.156716_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009340","article-title":"Long-term prognosis of patients with coexisting obesity and malnutrition after acute myocardial infarction: a cohort study","volume":"16","author":"Kong","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"10.1016\/j.metabol.2026.156716_bb0115","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1111\/dom.15660","article-title":"The prognostic value of metabolic dysfunction-associated steatotic liver disease in acute myocardial infarction: a propensity score-matched analysis","volume":"26","author":"Kong","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"13","key":"10.1016\/j.metabol.2026.156716_bb0120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jacc.2023.06.045","article-title":"Clinical pathway for coronary atherosclerosis in patients without conventional modifiable risk factors: JACC state-of-the-art review","volume":"82","author":"Figtree","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2026.156716_bb0125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijcard.2022.09.062","article-title":"Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: results from a global meta-analysis of 1,285,722 patients","volume":"371","author":"Kong","year":"2023","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.metabol.2026.156716_bb0130","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/dom.16062","article-title":"Long-term all-cause mortality of metabolic-dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: a retrospective cohort study","volume":"27","author":"Koh","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2026.156716_bb0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pcad.2025.12.004","article-title":"Evaluation of the PREVENT risk assessment tool and visceral adiposity: insights from the UK biobank","volume":"94","author":"Alebna","year":"2026","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2026.156716_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101009","article-title":"Performance of PREVENT and pooled cohort equations for predicting 10-year ASCVD risk in the UK biobank","volume":"22","author":"Ambrosio","year":"2025","journal-title":"Am J Prev Cardiol"},{"issue":"22","key":"10.1016\/j.metabol.2026.156716_bb0145","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","volume":"86","author":"Global, Regional, and National Burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023","year":"2025","journal-title":"JACC"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"issue":"3","key":"10.1016\/j.metabol.2026.156716_bb0155","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.metabol.2026.156716_bb0160","doi-asserted-by":"crossref","unstructured":"Chew NWS, Kannan S, Chong B, Chin Y, Muthiah M. Editorial: the heart of NAFLD. Front Med (Lausanne) 2023;10:1209625.","DOI":"10.3389\/fmed.2023.1209625"},{"issue":"10518","key":"10.1016\/j.metabol.2026.156716_bb0165","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the global burden of disease study 2023","volume":"406","author":"Mark","year":"2025","journal-title":"Lancet"},{"issue":"10062","key":"10.1016\/j.metabol.2026.156716_bb0170","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2026.156716_bb0175","series-title":"GBD Results","author":"Institute For Health Metrics and Evaluation","year":"2026"},{"issue":"10440","key":"10.1016\/j.metabol.2026.156716_bb0180","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2026.156716_bb0185","doi-asserted-by":"crossref","unstructured":"Mensah GA, Fuster V, Murray CJL, Roth GA. Global burden of cardiovascular diseases and risks, 1990-2022. J Am Coll Cardiol 2023;82(25):2350\u2013473.","DOI":"10.1016\/j.jacc.2023.11.007"},{"key":"10.1016\/j.metabol.2026.156716_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101850","article-title":"Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the global burden of disease study 2019","volume":"57","author":"Chong","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.metabol.2026.156716_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155402","article-title":"The global syndemic of metabolic diseases in the young adult population: a consortium of trends and projections from the global burden of disease 2000-2019","volume":"141","author":"Chong","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156716_bb0200","doi-asserted-by":"crossref","unstructured":"Goh RSJ, Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Kueh MTW, et al. The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions. Lancet Reg Health West Pac 2024;49:101138.","DOI":"10.1016\/j.lanwpc.2024.101138"},{"issue":"10513","key":"10.1016\/j.metabol.2026.156716_bb0205","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","volume":"406","year":"2025","journal-title":"Lancet"},{"issue":"10481","key":"10.1016\/j.metabol.2026.156716_bb0210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","author":"Ng","year":"2025","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.metabol.2026.156716_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2026.102775","article-title":"Modifiable risk factors for atrial fibrillation\/flutter in the Association of Southeast Asian Nations: global burden of disease 2021","volume":"5","author":"Baig","year":"2026","journal-title":"JACC Adv"},{"key":"10.1016\/j.metabol.2026.156716_bb0220","doi-asserted-by":"crossref","unstructured":"Yong JN, Ng CH, Lee CW, Chan YY, Tang ASP, Teng M, et al. Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis. Hepatol Int 2022;16(2):269\u201381.","DOI":"10.1007\/s12072-022-10319-6"},{"issue":"3","key":"10.1016\/j.metabol.2026.156716_bb0225","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/oby.23658","article-title":"A two-decade population-based study on the effect of hypertension in the general population with obesity in the United States","volume":"31","author":"Kong","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2026.156716_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.942753","article-title":"Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality","volume":"9","author":"Ng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2026.156716_bb0235","doi-asserted-by":"crossref","unstructured":"Hyndman RJ, Khandakar Y. Automatic time series forecasting: The forecast package for R. J Stat Softw 2008;27(3):1\u201322.","DOI":"10.18637\/jss.v027.i03"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1467-9868.2010.00749.x","article-title":"Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models","volume":"73","author":"Wood","year":"2011","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"4","key":"10.1016\/j.metabol.2026.156716_bb0245","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ijforecast.2006.03.001","article-title":"Another look at measures of forecast accuracy","volume":"22","author":"Hyndman","year":"2006","journal-title":"Int J Forecast"},{"key":"10.1016\/j.metabol.2026.156716_bb0250","series-title":"An Introduction to the Bootstrap","author":"Efron","year":"1994"},{"issue":"4","key":"10.1016\/j.metabol.2026.156716_bb0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.6028\/jres.070C.025","article-title":"Notes on the use of propagation of error formulas","volume":"70C","author":"Ku","year":"1966","journal-title":"J Res Natl Bur Stand C Eng Instrum"},{"key":"10.1016\/j.metabol.2026.156716_bb0260","series-title":"R: A language and environment for statistical computing","author":"Team RC","year":"2025"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/gh.1278","article-title":"World heart federation roadmap for secondary prevention of cardiovascular disease: 2023 update","volume":"19","author":"Laranjo","year":"2024","journal-title":"Glob Heart"},{"key":"10.1016\/j.metabol.2026.156716_bb0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ahj.2019.05.007","article-title":"Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: data from the FAST-MI program 1995-2015","volume":"214","author":"Puymirat","year":"2019","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.metabol.2026.156716_bb0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jacc.2025.04.061","article-title":"The global Syndemic of modifiable cardiovascular risk factors projected from 2025 to 2050","volume":"86","author":"Chong","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.metabol.2026.156716_bb0280","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical Management of Cardiovascular-Kidney-Metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.metabol.2026.156716_bb0285","doi-asserted-by":"crossref","first-page":"21630","DOI":"10.1002\/jcp.28821","article-title":"Impact of different ectopic fat depots on cardiovascular and metabolic diseases","volume":"234","author":"Ferrara","year":"2019","journal-title":"J Cell Physiol"},{"issue":"24","key":"10.1016\/j.metabol.2026.156716_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031230","article-title":"Immune activation mediates the association of advanced hepatic fibrosis with adverse outcomes in patients with coronary artery disease","volume":"12","author":"Jain","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2026.156716_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1692742","article-title":"Metabolic crossroads in insulin resistance: exploring lipid dysregulation and inflammation","volume":"16","author":"Saadati","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2026.156716_bb0300","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwag037","article-title":"The additive prognostic value of lipoprotein(a) for all-cause and cardiovascular mortality across the traditional cardiovascular risk continuum: analysis from NHANES III (1988-1994) with follow-up to 2019","author":"Al-Jarshawi","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2026.156716_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156600","article-title":"Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0-3","volume":"179","author":"Weng","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156716_bb0310","article-title":"Systematic review of cardiovascular care delivery across health systems in the Asia-Pacific: a regional roadmap for strengthening cardiovascular care","volume":"71","author":"Chew","year":"2026","journal-title":"Lancet Reg Health West Pac"},{"issue":"2","key":"10.1016\/j.metabol.2026.156716_bb0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eprac.2021.09.013","article-title":"Antidiabetic medications for type 2 diabetics with nonalcoholic fatty liver disease: evidence from a network Meta-analysis of randomized controlled trials","volume":"28","author":"Ng","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.metabol.2026.156716_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2026.06.008","article-title":"GLP-1 receptor agonists and primary prevention of Cancer therapy-related cardiac dysfunction","author":"Javaid","year":"2026","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40842-026-00299-z","article-title":"Projected reduction in major adverse cardiovascular events among high-risk U.S. adults with type 2 diabetes eligible for oral semaglutide: a SOUL trial\u2013based analysis using NHANES (1988\u20132018) cycles","volume":"12","author":"Al-jarshawi","year":"2026","journal-title":"Cardiovasc Diabetol Endocrinol Rep"},{"key":"10.1016\/j.metabol.2026.156716_bb0330","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-025-02800-7","article-title":"Natural history and outcomes of medically treated coronary artery disease: insights from reconstructed individual patient data of 29 randomized trials","author":"Mahesh","year":"2025","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.metabol.2026.156716_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjcard.2022.02.044","article-title":"Meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting for left main narrowing","volume":"173","author":"Chew","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2026.156716_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.822228","article-title":"Coronary artery bypass grafting versus percutaneous coronary intervention for multivessel coronary artery disease: a one-stage Meta-analysis","volume":"9","author":"Chew","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2026.156716_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.04.005","article-title":"Multimorbidity and quality of life: systematic literature review and meta-analysis","volume":"53","author":"Makovski","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.metabol.2026.156716_bb0350","unstructured":"World Health Organization. UN decade of healthy ageing: Plan of action 2021\u20132030. Geneva: World Health Organization; 2020 25 May 2026."},{"issue":"10440","key":"10.1016\/j.metabol.2026.156716_bb0355","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"9967","key":"10.1016\/j.metabol.2026.156716_bb0360","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(14)61347-7","article-title":"The burden of disease in older people and implications for health policy and practice","volume":"385","author":"Prince","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2026.156716_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2022.112056","article-title":"Association between metabolic syndrome and risk of both prevalent and incident frailty in older adults: findings from the Irish longitudinal study on ageing (TILDA)","volume":"172","author":"McCarthy","year":"2023","journal-title":"Exp Gerontol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156716_bb0370","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12603-021-1609-3","article-title":"Frailty and quality of life in older adults with metabolic syndrome - findings from the healthy older people everyday (HOPE) study","volume":"25","author":"Chen","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.metabol.2026.156716_bb0375","doi-asserted-by":"crossref","unstructured":"Weight N, Moledina S, Ullah M, Wijeysundera HC, Davies S, Chew NWS, et al. Impact of Chronic Kidney Disease on the Processes of Care and Long&#x2010;Term Mortality of Non&#x2013;ST&#x2010;Segment&#x2013;Elevation Myocardial Infarction: A Nationwide Cohort Study and Long&#x2010;Term Follow&#x2010;Up. J Am Heart Assoc 2024;13(16):e032671.","DOI":"10.1161\/JAHA.123.032671"},{"issue":"4","key":"10.1016\/j.metabol.2026.156716_bb0380","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/dom.14950","article-title":"Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction","volume":"25","author":"Chin","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0385","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in cardiovascular disease via modified Delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2026.156716_bb0390","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0167-5273(15)31026-3","article-title":"Global burden of CVD: focus on secondary prevention of cardiovascular disease","volume":"201","author":"Bansilal","year":"2015","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156716_bb0395","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.eprac.2022.10.006","article-title":"Barriers and facilitators to engagement with a Weight management intervention in Asian patients with overweight or obesity: a systematic review","volume":"29","author":"Anand","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/j.metabol.2026.156716_bb0400","series-title":"Tackling NCDs: \u201cbest buys\u201d and other recommended interventions for the prevention and control of noncommunicable diseases","author":"World Health Organization","year":"2024"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0405","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1468-0009.2009.00548.x","article-title":"Schools and obesity prevention: creating school environments and policies to promote healthy eating and physical activity","volume":"87","author":"Story","year":"2009","journal-title":"Milbank Q"},{"issue":"10481","key":"10.1016\/j.metabol.2026.156716_bb0410","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(25)00397-6","article-title":"Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the global burden of disease study 2021","volume":"405","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2026.156716_bb0415","article-title":"Effectiveness of an artificial intelligence-assisted app for improving eating behaviors: mixed methods evaluation","volume":"26","author":"Chew","year":"2024","journal-title":"J Med Internet Res"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0420","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10365","key":"10.1016\/j.metabol.2026.156716_bb0425","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.metabol.2026.156716_bb0430","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/ehjqcco\/qcac060","article-title":"Meta-analysis of the placebo and nocebo effects associated with placebo treatment in randomized trials of lipid-lowering therapies","volume":"9","author":"Chin","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"5","key":"10.1016\/j.metabol.2026.156716_bb0435","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/oby.24002","article-title":"Efficacy and safety of tirzepatide, GLP-1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis","volume":"32","author":"Pan","year":"2024","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0440","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12933-025-02840-3","article-title":"Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety","volume":"24","author":"Tang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.metabol.2026.156716_bb0445","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/a-1877-9656","article-title":"Nonalcoholic steatohepatitis drug development pipeline: an update","volume":"42","author":"Chew","year":"2022","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.1016\/j.metabol.2026.156716_bb0450","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11883-022-01027-5","article-title":"Comprehensive review and updates on holistic approach towards non-alcoholic fatty liver disease management with cardiovascular disease","volume":"24","author":"Chew","year":"2022","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0455","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/oby.23600","article-title":"The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review","volume":"31","author":"Llewellyn","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2026.156716_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156463","article-title":"Effect of GLP-1 receptor agonists and co-agonists on atrial fibrillation risk in overweight or obesity: systematic review and meta-analysis of randomized controlled trials","volume":"175","author":"Karakasis","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156716_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.metabol.2026.156716_bb0470","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70747","article-title":"Global prevalence, incidence, and outcomes of coexisting MASLD and chronic kidney disease: a meta-analysis","volume":"46","author":"Kueh","year":"2026","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.metabol.2026.156716_bb0475","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008381","article-title":"Patterns of prescribing sodium-glucose cotransporter-2 inhibitors for Medicare beneficiaries in the United States","volume":"14","author":"Sangha","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0480","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12933-020-01154-w","article-title":"Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes","volume":"19","author":"Schernthaner","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2026.156716_bb0485","doi-asserted-by":"crossref","unstructured":"Abu-Hantash H, Khader Y, Al-Saleh A, Al-Makhamreh H, Ibdah R, Ababneh M, et al. Clinical characteristics, management approaches, and outcomes of patients with heart failure: the Jordan heart failure registry. Front Cardiovasc Med 2025;12:1592002.","DOI":"10.3389\/fcvm.2025.1592002"},{"key":"10.1016\/j.metabol.2026.156716_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2026.120670","article-title":"The evolving therapeutic landscape of PCSK9 inhibition","volume":"414","author":"Mansfield","year":"2026","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.metabol.2026.156716_bb0495","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.046837","article-title":"Finerenone prescriptions in the United States (2021\u20132024) by physician specialty: analysis of use and potential in the cardiovascular-kidney-metabolic space","volume":"15","author":"Jelwan","year":"2026","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.metabol.2026.156716_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2026.102642","article-title":"Finerenone utilization for chronic kidney disease and diabetes: multicenter real-world study in the United States","volume":"5","author":"Lin","year":"2026","journal-title":"JACC Adv"},{"key":"10.1016\/j.metabol.2026.156716_bb0505","doi-asserted-by":"crossref","unstructured":"Harrison Stephen A, Bedossa P, Guy Cynthia D, Schattenberg J\u00f6rn M, Loomba R, Taub R, et al. A phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis. N Engl J Med 2024;390(6):497\u2013509.","DOI":"10.1056\/NEJMoa2309000"},{"issue":"7","key":"10.1016\/j.metabol.2026.156716_bb0510","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/oby.23453","article-title":"Comparison of mechanistic pathways of bariatric surgery in patients with diabetes mellitus: a Bayesian network meta-analysis","volume":"30","author":"Lin","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"10.1016\/j.metabol.2026.156716_bb0515","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13759","article-title":"Medication and supplement pharmacokinetic changes following bariatric surgery: a systematic review and meta-analysis","volume":"25","author":"Lajeunesse-Trempe","year":"2024","journal-title":"Obes Rev"},{"issue":"5","key":"10.1016\/j.metabol.2026.156716_bb0520","doi-asserted-by":"crossref","first-page":"658","DOI":"10.21037\/hbsn-21-520","article-title":"Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals","volume":"12","author":"Lim","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"8","key":"10.1016\/j.metabol.2026.156716_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100635","article-title":"Cardiovascular outcomes in acute coronary syndrome and malnutrition: a meta-analysis of nutritional assessment tools","volume":"2","author":"Lai","year":"2023","journal-title":"JACC Adv"},{"issue":"2","key":"10.1016\/j.metabol.2026.156716_bb0530","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-112469","article-title":"Evidence on implementing WHO package of essential non-communicable (PEN) diseases interventions: a systematic review protocol","volume":"16","author":"Xu","year":"2026","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.metabol.2026.156716_bb0535","first-page":"1779","article-title":"FIB-4 predicts MACE and cardiovascular mortality in patients with nonalcoholic fatty liver disease","volume":"38","author":"Chew","year":"2022","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0540","doi-asserted-by":"crossref","first-page":"26499","DOI":"10.1038\/s41598-025-12583-6","article-title":"Non-invasive scoring systems of liver fibrosis predict prognosis in the cohort with myocardial infarction","volume":"15","author":"Wong","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2026.156716_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.106902","article-title":"Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: a multidisciplinary consensus statement","author":"Kreutz","year":"2026","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1016\/j.metabol.2026.156716_bb0550","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-087451","article-title":"Barriers and facilitators for strengthening primary health systems for person-centred multimorbid care in low-income and middle-income countries: a scoping review","volume":"14","author":"Zezai","year":"2024","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.metabol.2026.156716_bb0555","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/eurjpc\/zwad133","article-title":"Higher risk of adverse cardiovascular outcomes in females with type 2 diabetes mellitus: an umbrella review of systematic reviews","volume":"30","author":"Yaow","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2026.156716_bb0560","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijcard.2023.04.042","article-title":"Socioeconomic deprivation and prognostic outcomes in acute coronary syndrome: a meta-analysis using multidimensional socioeconomic status indices","volume":"383","author":"Anand","year":"2023","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.metabol.2026.156716_bb0565","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jacasi.2026.01.027","article-title":"Myocardial infarction without standard modifiable risk factors from 2025-2040: forecast analysis of multinational, population-based study","volume":"6","author":"Cao","year":"2026","journal-title":"JACC Asia"},{"issue":"11","key":"10.1016\/j.metabol.2026.156716_bb0570","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/nutrit\/nuad163","article-title":"Anthropometric and cardiometabolic effects of polyphenols in people with overweight and obesity: an umbrella review","volume":"82","author":"Chew","year":"2024","journal-title":"Nutr Rev"},{"issue":"6","key":"10.1016\/j.metabol.2026.156716_bb0575","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.clnu.2024.05.019","article-title":"Effects of probiotics, prebiotics and synbiotics on anthropometric, cardiometabolic and inflammatory markers: an umbrella review of meta-analyses","volume":"43","author":"Teo","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.metabol.2026.156716_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.971484","article-title":"The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases","volume":"13","author":"Chew","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.metabol.2026.156716_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156573","article-title":"Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcomes","volume":"179","author":"Liu","year":"2026","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.metabol.2026.156716_bb0590","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12933-024-02552-0","article-title":"A sex-disaggregated analysis of the prognostic value of lean type 2 diabetes mellitus in the adult population with acute myocardial infarction","volume":"24","author":"Kong","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"10.1016\/j.metabol.2026.156716_bb0595","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.015985","article-title":"Response by Chong et al to letter regarding article, \u201cEpicardial adipose tissue assessed by computed tomography and echocardiography are associated with adverse cardiovascular outcomes: a systematic review and meta-analysis\u201d","volume":"16","author":"Chong","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.metabol.2026.156716_bb0600","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.015159","article-title":"Epicardial adipose tissue assessed by computed tomography and echocardiography are associated with adverse cardiovascular outcomes: a systematic review and meta-analysis","volume":"16","author":"Chong","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.metabol.2026.156716_bb0605","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","article-title":"Global burden of cardiovascular diseases: projections from 2025 to 2050","volume":"32","author":"Chong","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2026.156716_bb0610","article-title":"General public\u2019s knowledge, awareness, and perception of cardiometabolic diseases: data from a Singapore study population","volume":"10","author":"Anand","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.metabol.2026.156716_bb0615","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jamainternmed.2019.7194","article-title":"Clinical advances in sex- and gender-informed medicine to improve the health of all: a review","volume":"180","author":"Bartz","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.metabol.2026.156716_bb0620","first-page":"542","article-title":"The thin-fat phenotype and global metabolic disease risk","volume":"14","author":"Kurpad","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"Supplement_1","key":"10.1016\/j.metabol.2026.156716_bb0625","doi-asserted-by":"crossref","DOI":"10.2337\/db25-2116-LB","article-title":"2116-LB: body composition characteristics in a South Asian Indian population and its impact on metabolic parameters\u2014the \u201cGujarat phenotype\u201d","volume":"74","author":"MEHTA","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156716_bb0630","unstructured":"Kapoor N. Thin Fat Obesity: The Tropical Phenotype of Obesity. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright \u00a9 2000-2026, MDText.com, Inc.; 2000."},{"key":"10.1016\/j.metabol.2026.156716_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2023.02.023","article-title":"Mortality, cardiovascular, and medication outcomes in patients with myocardial infarction and underweight in a Meta-analysis of 6.3 million patients","volume":"196","author":"Lin","year":"2023","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.metabol.2026.156716_bb0640","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2337\/dci24-0046","article-title":"Lessons learned from epidemiology of type 2 diabetes in south Asians: Kelly west award lecture 2024","volume":"48","author":"Mohan","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156716_bb0645","series-title":"A systematic review and meta-analysis EClinicalMedicine","article-title":"The placebo response rate and nocebo events in obesity pharmacological trials","volume":"54","author":"Chin","year":"2022"},{"key":"10.1016\/j.metabol.2026.156716_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156596","article-title":"Cardiovascular health factors and altered proteomic landscapes in the progression of cardiovascular-kidney-metabolic syndrome: evidence from multi-cohorts in China, the UK, and the US","volume":"179","author":"Xue","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156716_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156424","article-title":"Inter-organ crosstalk in health and cardiovascular-renal-hepatic-metabolic disease: a multidisciplinary perspective","volume":"174","author":"Jia","year":"2026","journal-title":"Metabolism"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:02:16Z","timestamp":1787155336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":131,"alternative-id":["S0026049526002295"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156716","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156716"}}